90 related articles for article (PubMed ID: 11320847)
1. [Perspectives of gene therapy in ischemic syndromes of the lower limbs].
Melillo G; Capogrossi MC
Recenti Prog Med; 2001 Mar; 92(3):180-3. PubMed ID: 11320847
[TBL] [Abstract][Full Text] [Related]
2. [Therapeutic angiogenesis awakens hope. New blood vessels for arterial occlusive disease patients? (interview by Dr. Judith Neumaier)].
Diehm C
MMW Fortschr Med; 2002 Jul; 144(27-28):14. PubMed ID: 12198872
[No Abstract] [Full Text] [Related]
3. Cellular and molecular therapeutic modalities for arterial obstructive syndromes.
Staudacher DL; Preis M; Lewis BS; Grossman PM; Flugelman MY
Pharmacol Ther; 2006 Jan; 109(1-2):263-73. PubMed ID: 16243400
[TBL] [Abstract][Full Text] [Related]
4. Gene therapy progress and prospects: therapeutic angiogenesis for limb and myocardial ischemia.
Khan TA; Sellke FW; Laham RJ
Gene Ther; 2003 Feb; 10(4):285-91. PubMed ID: 12595887
[TBL] [Abstract][Full Text] [Related]
5. [Angiogenic gene therapy for ischemic heart disease].
Ueno H
Nihon Rinsho; 1998 Oct; 56(10):2645-52. PubMed ID: 9796333
[TBL] [Abstract][Full Text] [Related]
6. Gene therapy of the ischemic lower limb--Therapeutic angiogenesis.
Bobek V; Taltynov O; Pinterova D; Kolostova K
Vascul Pharmacol; 2006 Jun; 44(6):395-405. PubMed ID: 16698324
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis for the treatment of vascular diseases.
Chawla PS; Keelan MH; Kipshidze N
Int Angiol; 1999 Sep; 18(3):185-92. PubMed ID: 10688416
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--Part II.
Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
Cardiol Rev; 2008; 16(5):219-29. PubMed ID: 18708823
[TBL] [Abstract][Full Text] [Related]
9. [Therapeutic angiogenesis for ischemic diseases].
Aoki M; Morishita R
Nihon Rinsho; 2006 Apr; 64(4):762-8. PubMed ID: 16613196
[TBL] [Abstract][Full Text] [Related]
10. Growth factors for therapeutic angiogenesis in peripheral arterial disease.
Jones WS; Annex BH
Curr Opin Cardiol; 2007 Sep; 22(5):458-63. PubMed ID: 17762548
[TBL] [Abstract][Full Text] [Related]
11. Endothelial dysfunction--an obstacle of therapeutic angiogenesis.
Sun L; Bai Y; Du G
Ageing Res Rev; 2009 Oct; 8(4):306-13. PubMed ID: 19389489
[TBL] [Abstract][Full Text] [Related]
12. Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
Lekas M; Lekas P; Latter DA; Kutryk MB; Stewart DJ
Curr Opin Cardiol; 2006 Jul; 21(4):376-84. PubMed ID: 16755208
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic angiogenesis: a new treatment approach for ischemic heart disease--part I.
Ahn A; Frishman WH; Gutwein A; Passeri J; Nelson M
Cardiol Rev; 2008; 16(4):163-71. PubMed ID: 18562806
[TBL] [Abstract][Full Text] [Related]
14. Gene and stem cell therapy in peripheral arterial occlusive disease.
Kalka C; Baumgartner I
Vasc Med; 2008; 13(2):157-72. PubMed ID: 18593804
[TBL] [Abstract][Full Text] [Related]
15. The molecular mechanisms of angiogenesis: a new approach to cardiovascular diseases.
Brizzi MF; Formato L; Bonamini R
Ital Heart J; 2001 Feb; 2(2):81-92. PubMed ID: 11256548
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic angiogenesis: a case for targeted, regulated gene delivery.
Webster KA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):113-25. PubMed ID: 11186327
[TBL] [Abstract][Full Text] [Related]
17. Non-viral vectors for gene therapy: clinical trials in cardiovascular disease.
Shah PB; Losordo DW
Adv Genet; 2005; 54():339-61. PubMed ID: 16096018
[TBL] [Abstract][Full Text] [Related]
18. Angiogenesis therapy in ischemic disease.
Silvestre JS; Lévy BI
Arch Mal Coeur Vaiss; 2002 Mar; 95(3):189-96. PubMed ID: 11998334
[TBL] [Abstract][Full Text] [Related]
19. Growth factors for therapeutic angiogenesis in hypercholesterolemic erectile dysfunction.
Xie D; Annex BH; Donatucci CF
Asian J Androl; 2008 Jan; 10(1):23-7. PubMed ID: 18087640
[TBL] [Abstract][Full Text] [Related]
20. Regional angiogenesis with vascular endothelial growth factor in peripheral arterial disease: a phase II randomized, double-blind, controlled study of adenoviral delivery of vascular endothelial growth factor 121 in patients with disabling intermittent claudication.
Rajagopalan S; Mohler ER; Lederman RJ; Mendelsohn FO; Saucedo JF; Goldman CK; Blebea J; Macko J; Kessler PD; Rasmussen HS; Annex BH
Circulation; 2003 Oct; 108(16):1933-8. PubMed ID: 14504183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
